Clinical Trials Logo

Filter by:
NCT ID: NCT02438046 Not yet recruiting - Gingival Recession Clinical Trials

Platelet Rich Fibrin in the Treatment of Palatal Wounds

Start date: May 2015
Phase: Phase 4
Study type: Interventional

In this study it will be investigated the usefulness of Platelet-Rich Fibrin (PRF) on in the epithelialized connective tissue graft palatal donor site healing acceleration and in the patient's morbidity reduction. Forty patients, with at least one gingival recession will be treated by a coronally advanced flap (CAF) with connective tissue graft(CTG) resulting from the de-epithelialization of a free gingival graft. In the test group (20 patients) a quadruple layer of PRF membrane will be placed over the palatal wounds; conversely, the control group patients will be treated by an absorbable gelatin sponge. Patients will be monitored at 1, 2, 3 and 4 weeks after surgery for the complete re-epithelialization of the palatal wound (CWE), the alteration of sensibility (AS) around the wound area, the post-operative discomfort (D), and the changes of feeding habits (CFH) by a visual analogic scale (VAS) evaluation. Furthermore, the analgesics consumption and the existence of delayed bleeding from the palatal wound (DWB) during the first post-operative week will be assessed.

NCT ID: NCT02430831 Not yet recruiting - Infantile Colic Clinical Trials

Effect of Milk Formula Supplemented With L. Reuteri on Crying Time in Colicky Infants Less Than 3 Months Old

Start date: May 2015
Phase: Phase 4
Study type: Interventional

Study type: Randomized controlled trial with two parallel arms Objectives Primary : Demonstrate that daily supplementation of colicky infants with Nidina formula containing L. reuteri DSM 17938 decreases the daily crying duration at 21 days Secondary : Evaluate the effects of daily supplementation of colicky infants with Nidina formula containing L. reuteri DSM 17938 measured as 1. the number of "responders" or the "treatment success" (ie infants for which defined as the percentage of children achieving a reduction in the daily average crying time >50% in 3 weeks. (day 1 to day 21 of the study) 2. maternal depression and family functioning scoring

NCT ID: NCT02402816 Not yet recruiting - Heart Failure Clinical Trials

MPP Narrow QRS:Pilot Study on Multipoint Pacing in Patients With QRS Beetwen 100 and 130 Msec

Start date: May 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the impact of the Multi Point Pacing (MPP) feature in the treatment of patients with QRS beetwen 100 and 130 msec in patients candidate to ICD implant.

NCT ID: NCT02400099 Not yet recruiting - Obesity Clinical Trials

Protein-rich Diet and NAFLD in Bariatric Surgery

Start date: June 2015
Phase: N/A
Study type: Interventional

Randomized, single-blind, trial to determine whether a high-protein, low calorie diet is more effective than a control low calorie diet in improving the metabolic and histologic abnormalities in patients with Non-alcoholic Fatty Liver Disease undergoing bariatric surgery.

NCT ID: NCT02393482 Not yet recruiting - Quality of Life Clinical Trials

Psychological Impact of Amenorrhea in Women With Endometriosis

Start date: June 2021
Phase: Phase 4
Study type: Interventional

The purpose of the study is to evaluate the impact on quality of life, psychological health, sexuality and chronic pain of therapies which determine amenorrhea in symptomatic women with endometriosis, through the administration of self reported questionnaires. Amenorrhea in the first group is caused by balanced assumption of estroprogestins, in the second group is caused by GnRHa-induced hypoestrogenism.

NCT ID: NCT02386059 Not yet recruiting - Clinical trials for Postoperative Nausea and Vomiting

Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Vitrectomy Under Local Anesthesia

Start date: March 2015
Phase: Phase 4
Study type: Interventional

Vitreoretinal surgery is associated with a considerable incidence of postoperative nausea and vomiting (PONV), which is reported to be as high as 60%. Reasons for this high incidence may be the long duration of surgery and anesthesia and the high degree of manipulation of the eye. Postoperative vomiting after vitrectomy is an important risk factor for the onset of several complications, such as suprachoroidal hemorrhage, with disastrous visual consequences. To date there is no evidence as to the possible protective effect of anti-emetic therapy with regard to interventions of vitrectomy performed under local anesthesia. In this prospective, randomized, multicenter, double blind study, we evaluated the efficacy of Ondansetron alone, Dexamethasone alone and in combination in controlling nausea and vomiting in patients undergoing vitrectomy under local anesthesia.

NCT ID: NCT02373995 Not yet recruiting - Graves' Disease Clinical Trials

Role of the Microbiome in Graves' Orbitopathy

Indigo
Start date: February 2015
Phase: Phase 1/Phase 2
Study type: Interventional

Graves' orbitopathy (GO), also known as thyroid eye disease, affects approximately 3 million people in Europe with an estimated socioeconomic burden of 6.4 billion euros per annum. GO is a complication of Graves' disease which is an autoimmune disease and the commonest cause of an overactive thyroid gland. The treatment of GO remains unsatisfactory and the majority of patients report long-term impairment of quality of life. The effects of gut derived antigens, from micro-organisms and nutrients, on the autoimmune response will be tested in the animal model by probiotic and "contra-biotic" intervention. In the Indigo interventional trial the investigators will add to the standard anti-thyroid drug treatment (ATD) a specifically designed probiotics (LAB4, Cultech Ltd., West Glamorgan, UK) to assess whether it is possible to modify the microbiome in GD patients and improve their immunological status.

NCT ID: NCT02338505 Not yet recruiting - Clinical trials for Benign, Premalignant and Malignant Gynecological Disease Confined to the Pelvis

Teleassisted Surgery for Gynecological Disease in Obese Patients - OB-ALFX

OB-ALFX
Start date: February 2015
Phase: Phase 2
Study type: Interventional

Phase II prospective single-institutional study.

NCT ID: NCT02301728 Not yet recruiting - Clinical trials for Short Chain Fatty Acids Concentration in Breast Milk

Study on Short Chain Fatty Acids Concentration in Breast Milk and Its Correlation With the Maternal Diet

Start date: December 2014
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether the acetate, butyrate and propionate concentration in breast milk and to evaluate the possible correlation of these concentrations with maternal diet.

NCT ID: NCT02295852 Not yet recruiting - Hypertension Clinical Trials

Increasing Calcium Dietary Intake Helps to Control Blood Presure and Body Weight

Start date: December 2014
Phase: N/A
Study type: Interventional

Mediterranean diet is relatively poor in calcium (about 700 mg/daily) whilst there are several reports indicating beneficial effects of calcium-rich diets. Aim of the preset study is to evaluate the effects of a low-sodium, low-lipid diet enriched in calcium, mainly from vegetables instead of dairy products, on blood pressure, body weight a main parameters of the glucose and lipid metabolisms. This study is a randomized, parallel group trial that will be performed in the Outpatient Clinic. At least 150 patients with arterial hypertension and/or increased body weight (IMC> 28 kg/m2) will enter the study program. After a 3 month low-lipid low-salt diet that will be prescribed to all patients, they will be divided in two groups. The first will change the diet to that similar for total calories, percent composition of macronutrients and salt but enriched in calcium (about 1200 mg/daily) whilst the alternative group will continue the first diet. The observation period will be of 1 year with anthropometric (body weight and height, waist circumference), hemodynamic (blood pressure and heart rate) and metabolic (cholesterol, triglycerides, fasting blood glucose, uric acid, calcium, phosphorus, sodium and potassium) controls after 3-6 and 12 months.